[EN] NOVEL HETEROCYCLIC COMPOUNDS USEFUL AS AURORA A SELECTIVE INHIBITORS [FR] NOUVEAUX COMPOSÉS HÉTÉROCYCLIQUES UTILES EN TANT QU'INHIBITEURS SÉLECTIFS D'AURORA A
[EN] NOVEL HETEROCYCLIC COMPOUNDS USEFUL AS AURORA A SELECTIVE INHIBITORS [FR] NOUVEAUX COMPOSÉS HÉTÉROCYCLIQUES UTILES EN TANT QU'INHIBITEURS SÉLECTIFS D'AURORA A
[EN] NON-LYSOSOMAL GLUCOSYLCERAMIDASE INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE GLUCOSYLCÉRAMIDASE NON LYSOSOMALE ET LEURS UTILISATIONS
申请人:ALECTOS THERAPEUTICS INC
公开号:WO2020229968A1
公开(公告)日:2020-11-19
The invention provides compounds for inhibiting glucosylceramidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds.
Heterocyclic compounds useful as aurora a selective inhibitors
申请人:Jacobio Pharmaceuticals Co., Ltd.
公开号:US11384066B1
公开(公告)日:2022-07-12
Provided are compounds of formula (I), or pharmaceutically acceptable salts thereof, which can be used for inhibiting the activity of Aurora A and treating cancer mediated by Aurora A.
所提供的式 (I) 化合物或其药学上可接受的盐类可用于抑制 Aurora A 的活性和治疗由 Aurora A 介导的癌症。